Sun Pharma Advanced Research Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 ,inter alia, to consider and approve Unaudited ....
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharma Advanced Research Company (SPARC) has informed the stock exchanges that its Board of Directors will meet on Monday, August 4, 2025. The main agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2025 (Q1 FY26). The filing is made under SEBI's Listing Obligations and Disclosure Requirements (Regulation 29). The company's trading window for insiders has been closed since July 1, 2025 and will remain shut until 48 hours after the results are announced. No financial figures or business updates have been disclosed in this intimation.
This is a routine pre-results announcement and is not material to the stock price on its own. Investors should watch for the actual Q1 results on August 4 for insights into revenue growth, profitability, and R&D progress at SPARC.